(Q36798592)

16 August 2017

1 reference

title

Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review (English)

1 reference

16 August 2017

main subject

evidence-based medicine

1 reference

1 reference

Gough SC

1

1 reference

16 August 2017

Tibaldi J

series ordinal

2

1 reference

16 August 2017

publication date

1 January 2007

1 reference

Clinical Drug Investigation

16 August 2017

published in

1 reference

16 August 2017

volume

27

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

299-324

1 reference

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00044011-200727050-00002

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

21 January 2018

1 reference

12 December 2020

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes

1 reference

12 December 2020

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

12 December 2020

Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of insulin aspart

1 reference

12 December 2020

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin

1 reference

12 December 2020

Interval between insulin injection and eating in relation to blood glucose control in adult diabetics

1 reference

12 December 2020

Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?

1 reference

12 December 2020

Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus

1 reference

12 December 2020

Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

1 reference

12 December 2020

Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy

1 reference

12 December 2020

Type 2 diabetes in children and adolescents. American Diabetes Association

1 reference

12 December 2020

Standards of medical care in diabetes

1 reference

12 December 2020

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The effects of improved glycemic control on complications in type 2 diabetes

1 reference

12 December 2020

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart

1 reference

12 December 2020

Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes

1 reference

12 December 2020

Using Continuous Glucose Monitoring to Measure the Frequency of Low Glucose Values When Using Biphasic Insulin Aspart 30 Compared With Biphasic Human Insulin 30: A double-blind crossover study in individuals with type 2 diabetes

1 reference

12 December 2020

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

12 December 2020

A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes

1 reference

12 December 2020

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

1 reference

12 December 2020

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes

1 reference

12 December 2020

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US

1 reference

12 December 2020

Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal

1 reference

12 December 2020

Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.

1 reference

12 December 2020

Insulin aspart : an evidence-based medicine review

1 reference

12 December 2020

Neurosurgical causes of scoliosis in patients with myelomeningocele: an evidence-based literature review

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Thiazolidinediones and insulin: rationale for use and role of combination therapy in type 2 diabetes mellitus

1 reference

12 December 2020

Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes

1 reference

12 December 2020

Postprandial hyperglycemia and diabetes complications: is it time to treat?

1 reference

12 December 2020

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study

1 reference

12 December 2020

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

12 December 2020

How evidence-based are publications in clinical ophthalmic journals?

1 reference

12 December 2020

Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues

1 reference

12 December 2020

Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride

1 reference

12 December 2020

Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

1 reference

12 December 2020

Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes

1 reference

12 December 2020

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

12 December 2020

Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States

1 reference

12 December 2020

10.2165/00044011-200727050-00002

Identifiers

DOI

1 reference

16 August 2017

1 reference